CL
ALXN

CIM LLC’s Alexion Pharmaceuticals ALXN Stock Holding History

CIM LLC’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-23,234
Closed -$4.2M – 85
2015
Q2 		$4.2M Sell
23,234
-1,761
-7% -$304K 1.99% 21
2015
Q1 		$4.33M Sell
24,995
-308
-1% -$55.8K 2.02% 22
2014
Q4 		$4.68M Buy
25,303
+769
+3% +$142K 2.21% 21
2014
Q3 		$4.07M Buy
24,534
+562
+2% +$92.3K 2.02% 22
2014
Q2 		$3.75M Buy
+23,972
New +$3.79M 1.89% 22

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CIM LLC's ALXN Position: Q3 2015 in Review

CIM LLC sold out of Alexion Pharmaceuticals (ALXN) in Q3 2015, closing a stake of 23,234 shares — an estimated $4.2M sold.

CIM LLC first reported a position in ALXN in Q2 2014 and held it in 5 quarters. The position peaked at $4.68M in Q4 2014. 515 funds tracked by Wall St. Rank hold ALXN as of Q3 2015.

  • CIM LLC reported no remaining Alexion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • CIM LLC sold 23,234 Alexion Pharmaceuticals shares in Q3 2015, an estimated $4.2M.
  • CIM LLC first reported a position in Alexion Pharmaceuticals in Q2 2014 and held it in 5 quarters.
  • CIM LLC's Alexion Pharmaceuticals position peaked at $4.68M in Q4 2014.
  • 515 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2015.

Based on CIM LLC's 13F filing for Q3 2015, filed 30 Oct 2015.